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Abstract 
Background: Clusters of circulating tumor cells (CTCs), despite being rare, may account for 
more than 95% of metastases. Cells in these clusters do not undergo a complete epithelial-to-
mesenchymal transition (EMT) but retain some epithelial traits as compared to individually 
disseminating tumor cells. Determinants of single cell dissemination versus collective 
dissemination remain elusive. Inflammatory breast cancer (IBC), a highly aggressive breast 
cancer subtype that chiefly metastasizes via CTC clusters, is a promising model for studying 
mechanisms of collective tumor cell dissemination. Previous studies on breast cancer and adult 
acute myeloid leukemia, motivated by a theory that suggests physical systems with hierarchical 
organization tend to be more adaptable, have found that the expression of metastasis associated 
genes is more hierarchically organized in cases of successful metastases. 
Methods: We used the cophenetic correlation coefficient (CCC) to quantify the hierarchical 
organization in the expression networks of two distinct gene sets, collective dissemination 
associated genes and IBC associated genes, in cancer cell lines and in tumor samples from breast 
cancer patients. Hypothesizing that a higher CCC for collective dissemination associated genes 
and for IBC associated genes would be associated with a more evident epithelial phenotype and 
with worse outcomes in breast cancer patients, we evaluated the correlation of CCC with 
different phenotypic groups. 
Results: The CCC of both gene networks, the collective dissemination associated gene network 
and the IBC associated gene network, was higher in (a) epithelial cell lines as compared to 
mesenchymal cell lines and (b) tumor samples from IBC patients, as compared to samples from 
non-IBC breast cancer patients. A higher CCC of both networks was also correlated with a 
higher rate of metastatic relapse in breast cancer patients. Neither the levels of CDH1 gene 
expression, nor gene set enrichment analysis could provide similar insights. 
Conclusions: These results suggest that retention of some epithelial traits in disseminating 
tumor cells as IBC progresses promotes successful breast cancer metastasis to distant organs. 
The CCC provides additional information regarding the organizational complexity of gene 
expression in comparison to differential gene expression analyses. We have shown that the CCC 
may be a useful metric for investigating the collective dissemination phenotype and a 
prognostic factor for IBC. 
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Background 
Metastasis is responsible for 90% of deaths from solid tumors [1]. It involves the escape of 
cancer cells from the site of the primary tumor, their entry into the circulatory system, and 
finally, colonization of and proliferation at a distant organ. However, this process is highly 
inefficient. Only an estimated 0.2% of the disseminated tumor cells are able to form a lesion at 
distant organ sites [2, 3]. A well-studied mechanism of metastasis is single cell dissemination 
where carcinoma cells acquire migratory and invasive traits via an epithelial-to-mesenchymal 
transition (EMT) [4]. These cells can then utilize blood or lymph circulation to reach distant 
organ sites, where they reacquire epithelial traits of cell-cell adhesion and apico-basal polarity 
via a mesenchymal-to-epithelial transition (MET) to establish metastases [4]. 
Recent studies have called into question the indispensability of a complete EMT and MET in 
metastasis [5] and have suggested collective migration of tumor cells via clusters of circulating 
tumor cells (CTCs) as an alternate mechanism of metastasis [6]. Clusters of tumor cells have 
been detected in the bloodstream of cancer patients even before the characterization of EMT as a 
driver of cancer metastasis  [7, 8]. These clusters of tumor cells can efficiently seed secondary 
tumors, exhibiting up to 50 times the metastatic potential of individually migrating tumor cells 
[9]. Tumor cell clusters accounted for >90% of metastases in a mouse model of breast cancer 
[10]. Abundance of CTC clusters in the bloodstream has been associated with significantly poor 
prognosis in breast cancer and in small cell lung cancer [9, 11]. Multiple factors are believed to 
be responsible for the heightened metastatic potential of these CTC clusters. These include 
effective response to mechanical signals and chemical gradients by cells in CTC clusters as 
compared to migrating single tumor cells [12, 13], better evasion of the host immune system 
[14], and potential cooperation among heterogeneous cell types in CTC clusters [15]. Studies 
have shown that collectively invading tumor cells from the primary lesion often co-express 
epithelial and mesenchymal markers [16–18]. Thus, cells in CTC clusters tend to manifest a 
hybrid epithelial / mesenchymal (E/M hybrid) phenotype and to retain cell-cell adhesion 
characteristics [6]. 
Inflammatory Breast Cancer (IBC) is a highly aggressive breast cancer subtype that has been 
reported to predominantly metastasize via CTC clusters [19]. Characterized by breast erythema, 
edema, and peau d’orange presenting with or without a noticeable tumoral mass [20, 21], IBC 
involves tumoral infiltrate in the dermal lymphatics, and about 30% of IBC patients have distant 
metastases at the time of diagnosis as compared to only 5% of non-IBC type breast cancer 
patients [22]. Though only 2-4% of breast cancer cases each year in the United States are of the 
IBC type, IBC patients account for 10% of the annual breast cancer related mortalities. A 
hallmark of IBC is the presence of cohesive clusters of tumor cells in the local lymph nodes [23], 
and IBC patients have larger and a higher frequency of CTC clusters as compared to non-IBC 
breast cancer patients [24]. Abundance of CTC clusters has been shown to be associated with 
poor progression free survival in IBC patients [24]. Despite their great propensity to 
metastasize, tumor cells in the primary lesion and in metastatic lesions of IBC maintain a high 
expression E-cadherin, a hallmark of epithelial cells [23]. IBC thus presents an exciting model 
for the study of collective dissemination of tumor cells via CTC clusters and of the prognostic 
potential of these clusters of migrating tumor cells. The results we present later in this paper 
strengthen the argument for investigating IBC to elucidate the mechanisms underlying 
collective dissemination of tumor cells. 
Here, we invoke concepts from theoretical models of evolution to investigate cluster-based 
dissemination of tumor cells and analogous IBC characteristics. Theoretical studies suggest that 
systems with a more hierarchical structure are more adaptable [25–27] due to their ability to 
efficiently span the space of possible states and are more robust to perturbations since a more 
hierarchical network structure has a buffering effect that hinders the propagation of local 
perturbations to a majority of nodes [27, 28]. Hierarchical organization, thus, emerges over time 
in physical systems evolving in a changing environment with a rugged fitness landscape 
exhibiting numerous peaks and valleys [26]. Given that tumor cells involved in metastasis and 
invasion progress through many different microenvironments [29–31], one can expect the 
expression of genes associated with a metastatic phenotype to be more hierarchically organized 
in instances of successful macrometastases as compared to instances with no metastasis. 
Here, we quantify the hierarchical organization in the expression of two distinct sets of genes, 
one associated with collective dissemination of tumor cells and the other related to IBC, in 
cancer cell lines and in breast cancer patients. For this purpose, we use the use the cophenetic 
correlation coefficient (CCC) metric. A higher CCC indicates greater hierarchical organization in 
the expression of genes. The CCC was first used for comparing tree-like relationships 
represented by different dendrograms [32]. It has been used previously to quantify the 
difference in expression of metastasis associated genes in breast cancer patients with different 
clinical outcomes [33] and to quantify the difference in expression of genes predictive of clinical 
outcome in adult acute myeloid leukemia in patients belonging to different risk categories [34]. 
The first set of genes investigated here includes 87 genes reported to be associated with 
collective dissemination of tumor cells as CTC clusters: genes differentially expressed in CTC 
clusters as compared to individual CTCs [10]. The second gene set includes 78 genes reported to 
be differentially expressed in IBC patients in comparison to non-IBC breast cancer patients [35]. 
We observed that the CCC for both of these gene sets is higher in (a) epithelial cell lines as 
compared to mesenchymal cell lines, and (b) IBC patients as compared to non-IBC breast cancer 
patients. A higher CCC further correlated with worse disease progression in breast cancer 
patients. In light of these observations, we propose that the metastatic aggressiveness of IBC 
potentially derives from the hierarchical organization in the expression of collective 
dissemination associated genes in metastasizing tumor cells. 
Methods 
Genes associated with collective dissemination of tumor cell clusters 
Using multicolor lineage tracking, Cheung et al. showed that polyclonal seeding by 
disseminated clusters of tumor cells is the dominant mechanism for metastasis in a mouse 
model of breast cancer [10]. These clusters accounted for more than 90% of distant organ 
metastases in mice [10]. Circulating tumor cell clusters were observed to be enriched in 
expression of the epithelial protein keratin 14 (K14), and 87 genes with enriched or depleted 
expression in K14+ cells as compared to K14- primary tumor cells were identified. Broadly, 
expression of adhesion complex associated genes was enriched and that of MHC Class II genes 
was depleted in K14+ cells. We used this set of genes as a signature of the collective 
dissemination phenotype. 
Genes associated with the Inflammatory Breast Cancer (IBC) phenotype 
Van Laere et al. obtained tumor samples from patients with breast adenocarcinoma: 137 samples 
from IBC patients and 252 samples from patients with non-IBC type breast cancer (non-IBC) 
[35]. IBC patients were selected in accordance with the consensus diagnostic criteria described 
by Dawood et al. [20]. RNA from the tumor samples was hybridized onto Affymetrix 
GeneChips (HGU133-series) to obtain the corresponding mRNA expression profiles. Linear 
regression models were employed to identify a set of 78 IBC specific genes which were 
differentially expressed in IBC tumor samples as compared to non-IBC tumor samples, 
independent of the molecular subtype of the tumor [35]. We used this set of genes as a signature 
of the IBC phenotype in breast cancer patients. 
Gene expression data from different cell lines 
We used two different datasets of gene expression in cell lines, each cell line classified as 
epithelial (E), mesenchymal(M), or epithelial / mesenchymal hybrid (E/M hybrid). The first 
dataset is from the study by Grosse-Wilde et al. [36]. A total of 24 clones established from 
HMLER cell lines (normal human mammary epithelial cells immortalized and transformed with 
hTERT and the oncogenes SV40LT and RAS [37]) were sorted into 13 CD24+/CD44- E clones 
and 11 CD24-/CD44+ M clones. The E clones and M clones displayed cobble-stone like 
morphology and dispersed, fibroblast morphology, respectively. 
The second dataset includes gene expression from the National Cancer Institute (NCI) 60 
anticancer drug screen (NCI-60), which includes panels of cell lines representing 9 distinct types 
of cancer: leukemia, colon, lung, central nervous system, renal, melanoma, ovarian, breast, and 
prostate [38]. The 60 cell lines have been classified into epithelial (E) (n = 11), mesenchymal (M) 
(n = 36), and epithelial / mesenchymal hybrid (E/M) (n = 11) categories on the basis of protein 
levels of E-cadherin and Vimentin [39] 
Gene expression data from tumor samples from IBC and non-IBC breast cancer patients 
We used three different datasets of gene expression in tumor samples obtained from breast 
cancer patients. Each patient in the three datasets was diagnosed with either inflammatory 
breast cancer (IBC) or non-IBC type breast cancer (non-IBC). Iwamoto et al. collected tumor 
biopsies prospectively from 82 patients with locally advanced disease. A clinical diagnosis of 
IBC was made in 25 of these patients [40]. Boersma et al. examined primary breast tumor 
samples from 50 patients, 15 of whom were diagnosed with IBC on the basis of the pathology 
and medical reports [41]. Finally, Woodward et al. obtained tissue samples from core biopsies of 
breast tissue in 40 breast cancer patients, 20 IBC and 20 non-IBC [21]. 
In Iwamoto et al. and Woodward et al., IBC diagnosis was made in patients with clinical 
presentation of breast erythema and edema over more than one-third of the breast. In Boersma 
et al., 9 IBC patients presented with erythema and edema, while 6 IBC patients exhibited 
pathology indicating dermal lymphatic invasion and tumor emboli. 
Definition of gene network for different phenotypic groups 
For each phenotypic group, e.g. NCI60 cell lines labeled as epithelial (E) or patients in the 
Iwamoto et al. [40] dataset diagnosed with IBC, and gene set, e.g. the gene set associated with 
IBC or the set of collective dissemination associated genes, we defined a network with the genes 
as nodes and weighted edges between these nodes. The weight of the edge between gene 𝑖 and 
gene 𝑗 in the phenotypic group 𝐺 was defined as 
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Here, 𝑒𝑚
𝑘  is the expression of gene 𝑚 in the sample 𝑘 (patient / cell line), 𝜇𝑚
𝐺  and 𝜎𝑚
𝐺  are the mean 
and standard deviation of the expression of gene 𝑚 in the phenotypic group 𝐺 respectively, and 
the summation is over all the patients or cell lines belonging to the group 𝐺. 
We constructed such networks for the epithelial and mesenchymal cell lines in the Grosse-
Wilde et al. [36] dataset and for the epithelial, mesenchymal, and epithelial / mesenchymal 
hybrid cell lines in the NCI60 dataset. Such networks were also constructed for IBC and non-
IBC patients in the three breast cancer datasets, Iwamoto et al. [40], Woodward et al. [21], and 
Boersma et al. [41], using each of the two gene sets described previously, genes associated with 
collective dissemination of tumor cell clusters and genes associated with the IBC phenotype. 
Calculation of the Cophenetic Correlation Coefficient 
To quantify the hierarchy in the expression of the two sets of genes in different groups of 
patients and cell lines, we used a metric called the cophenetic correlation coefficient (CCC) [32]. 
The CCC is a measure of how well a hierarchical clustering of nodes in a network reproduces 
the distances between nodes in the original network. Intuitively, the CCC is a measure of how 
tree-like a network is. Since a tree topology is a prototypical hierarchical structure, a measure of 
the tree-like characteristic of a network allows us to aptly quantify the underlying hierarchy in 
the structure of a network. 
For calculating the CCC of a given network, we defined the distance between nodes 𝑖 and 𝑗, 𝑑𝑖𝑗, 
as the Euclidean commute time distance (ECTD) between the nodes 𝑖 and 𝑗 [42]. The ECTD 
between nodes 𝑖 and 𝑗 depends not only on the weight of the edge between nodes 𝑖 and 𝑗, but 
also on the number of different possible paths between the two nodes. The ECTD decreases as 
the number of possible paths between the two nodes increases, and increases if any path 
between the two nodes becomes longer. This makes the ECTD suitable for clustering tasks. For 
a network with 𝑁 nodes, we generated a 𝑁 × 𝑁 matrix 𝐷 such that 𝐷𝑖𝑗 is the ECTD between 
nodes 𝑖 and 𝑗 [43]. The matrix 𝐷 is then used as an input to the average linkage hierarchical 
clustering algorithm [44] which generates a tree topology (𝑇), i.e. a dendrogram, that best 
approximates the distances between the nodes of the network given by the matrix 𝐷. We then 
calculated the CCC as the correlation between the original pairwise distances and the 
corresponding distances in the tree topology: 
𝐶𝐶𝐶 =  
∑ (𝐷𝑖𝑗 − 𝑑)(𝑇𝑖𝑗 − 𝑡)𝑖<𝑗
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         (2) 
Here, 𝑑 =< 𝐷𝑖𝑗 > is the mean of the original pairwise distances and 𝑡 =< 𝑇𝑖𝑗 > is the mean of 
the pairwise distance in the tree topology. If the original network is hierarchical, the distances 
between nodes in the tree topology obtained via hierarchical clustering (𝑇) will be highly 
correlated with the distances between nodes in the original network (𝐷). Hence, the CCC will be 
high. However, if the original network lacks any hierarchical organization, this correlation will 
be weak, and the CCC will be low. 
The CCC calculated for a network was normalized with respect to the CCC of random networks 
with the same set of nodes but re-distributed edge weights. For this, we generated 10 such 
random networks by shuffling entries in the matrix 𝐷 and then calculated the average of the 
CCCs of these random networks (CCCrand). The normalized CCC was then defined as 
𝐶𝐶𝐶𝑛𝑜𝑟𝑚 =
𝐶𝐶𝐶 − 𝐶𝐶𝐶𝑟𝑎𝑛𝑑
1 − 𝐶𝐶𝐶𝑟𝑎𝑛𝑑
         (3) 
Finally, to obtain the error in the estimate of CCC, we used the bootstrap method [45]. The 
method assumes that the distribution of gene expression in a patient or cell line group is the 
empirical distribution function of the observed expression of samples within the group. For a 
patient or cell line group with size 𝑝, we drew 𝑝 samples from the group with replacement and 
calculated CCCnorm for the sampled group. This sampling process was repeated 100 times to 
obtain 100 CCCnorm values. The standard error in the estimate of the CCCnorm for the group was 
then given as the sample standard deviation of the 100 sampled CCCnorm values. 
Results 
Higher CCC for the collective dissemination associated gene network in epithelial cell lines 
and in IBC patients. 
We constructed networks with genes associated with collective dissemination of tumor cell 
clusters [10], hereafter referred to as ‘collective dissemination associated’ genes, as nodes and 
weights of the edges between a pair of nodes defined according to equation (1). Such networks 
were constructed for the E and M cell lines from the gene expression data from Grosse-Wilde et 
al. [36] and for the cell lines in the NCI-60 anti-cancer drug screen [38] that have been 
categorized into E, M, and E/M hybrid classes [39]. The normalized CCC for these networks was 
calculated using the method described above, and the results are shown in fig. 1. E cell lines 
exhibited a significantly higher CCC as compared to M cell lines (p-value < 0.05) for the 
collective dissemination associated gene network in the dataset from Grosse-Wilde et al. [36], 
fig. 1 (A). In the NCI60 dataset, the CCC of the collective dissemination associated gene network 
was higher for E cell lines as compared to the pooled M and E/M hybrid cell lines, fig. 1(B). The 
bootstrap distribution of normalized CCC values for E cell lines was distinct from the 
distribution for M cell lines in the dataset from Grosse-Wilde et al. [36] and from the distribution 
for pooled M and E/M hybrid cell lines in the NCI-60 dataset (Kolmogorov–Smirnov test, p-
value < 10−5). 
We constructed similar networks for IBC and non-IBC patients using Affymetrix U133A profiles 
obtained by Iwamoto et al. [40]. Normalized CCC values for patients in the two groups are 
shown in fig. 2 (A). IBC patients exhibited a higher CCC for the network associated with 
collective dissemination of tumor cell clusters as compared to non-IBC breast cancer patients. 
The difference between the two groups in the dataset was significant (p-value < 0.05). Further, 
bootstrap distributions for the normalized CCC values for the two are groups were statistically 
distinct with p-value < 10−5 for the Kolmogorov–Smirnov test). However, we did not observe a 
significant trend for the breast cancer samples characterized by Boersma et al. [41] and for the 
samples characterized by Woodward et al. [21], fig. 2 (B) and (C). 
Higher CCC for the IBC associated gene network in epithelial cell lines and in IBC patients. 
We constructed networks with genes differentially expressed in tumor samples obtained from 
IBC patients as compared to tumor samples from non-IBC breast cancer patients, hereafter 
referred to as ‘IBC associated’ genes, as nodes. Weights of edges between pairs of nodes were 
defined using equation (1). Such networks were constructed for the E and M cell lines in the 
dataset from Gross-Wilde et al. [36] and for the E and pooled M + E/M hybrid cell lines in the 
NCI-60 dataset. Normalized CCC values for these groups of cell lines calculated using the 
method described above are shown in fig. 3. E cell lines displayed a higher CCC for the IBC 
associated gene network as compared to other cell lines in both datasets (p-value < 0.05 in each 
case). The bootstrap distributions of normalized CCC values for the two groups of cell lines 
were statistically distinct for both datasets (p < 10−5 for the Kolmogorov–Smirnov test in each 
case). 
Using Affymetrix U133A profiles from Iwamoto et al. [40], we constructed similar networks 
with IBC associated genes as nodes for both IBC and non-IBC breast cancer patients. 
Normalized CCC values for the two breast cancer patient groups are shown in fig. 4. The IBC 
group exhibited a significantly higher CCC for the IBC associated gene network as compared to 
the non-IBC patients group (p-value < 0.05). Bootstrap distributions for the two groups were 
again statistically distinct (p-value < 10−5 for the Kolmogorov–Smirnov test), fig. 4 (A). A 
similar trend in the CCC values for IBC and non-IBC patient groups was observed for breast 
cancer patients in the two other independent breast cancer datasets, Woodward et al. [21] and 
Boersma et al. [41], fig. 4 (B) and (C). 
Saunders and McClay used a well-understood gene regulatory network in the sea urchin 
embryo to identify transcription factors that control cell changes during EMT by perturbing 
individual transcription factors [46]. They further determined 30 human transcription factors 
homologous to those identified in sea urchins. We calculated the CCC of a network with these 
transcription factors, hereafter referred to as ‘canonical drivers of EMT’, as nodes for the IBC 
and non-IBC samples from each of the three breast cancer datasets, Iwamoto et al. [40], Boersma 
et al. [41], and Woodward et al. [21]. The weights of edges between different transcription factors 
were defined using equation (1). We observed that the IBC patient group exhibited a lower CCC 
for the network composed of canonical EMT drivers as compared to the non-IBC patient group 
in data from each of the three studies, fig. 5. 
Higher CCC for the two networks correlates with a higher rate of metastasis 
We constructed networks with the two sets of genes, collective dissemination associated and 
IBC associated, as nodes for breast cancer patients who exhibited metastatic relapse within 5 
years post-treatment, Wang et al. [47]. These patients were classified into two groups, those with 
metastatic relapse within 30 months and those with metastasis between 30 to 60 months post-
treatment. Edge weights were defined, once again, using equation (1). For both collective 
dissemination of tumor cells associated and IBC associated gene sets, the CCC was significantly 
higher (p < 0.05) for the patient group with early metastatic relapse of breast cancer, i.e. relapse 
within 30 months of treatment, as compared to patients with relatively late relapse, i.e. 
metastatic relapse after 30 months post-treatment, fig. 6 (A) and (B). The same trend was 
observed upon considering only estrogen-receptor-positive patients, fig. S1. There were too few 
samples from estrogen-receptor-negative patients for similar analysis. A similar trend was 
observed for small cell lung cancer (SCLC), another highly aggressive cancer subtype, which 
has also been reported to metastasize via cluster-based dissemination of tumor cells [48]. 
Patients with fewer than 10 months of disease free survival post-treatment exhibited a higher 
CCC for both collective dissemination associated and IBC associated gene sets as compared to 
patients with greater than 10 months of disease free survival post-treatment as computed from 
the data in the study by Rousseaux et al. [49], fig. 6 (C) and (D). We also compared CCCs of both 
collective dissemination associated and IBC associated gene networks in samples from breast 
cancer metastases to different organs and observed a higher CCC for metastases to skin and 
liver as compared to metastases to lymph nodes in the data from Kimbung et al. [50], fig. 7. 
We further explored whether the CCC for the collective dissemination associated gene network 
and the IBC associated gene network were different in breast cancer patients with metastatic 
relapse within 5 years post-treatment and those with no metastasis during this follow-up period 
as computed from the data in the study by Wang et al. [47]. Intriguingly, we observed that the 
CCC of both networks was significantly higher (p < 0.05 in each case) for patients with no 
metastasis during the 5-year follow up period as compared to patients with metastatic relapse 
during the follow up, fig. 8 (A) and (B). A similar trend was observed for breast tumor samples 
from the cancer genome atlas (TCGA) for patients who exhibited relapse during the follow up 
period and those who did not [51], fig. 8 (C) and (D). Given that healthy breast cells are 
inherently epithelial, a higher CCC for the patient group with no metastatic relapse during the 
follow up period may be a consequence of the tumor being at initial stages of progression 
towards a metastatic phenotype at the time of diagnosis and sample collection in these patient 
groups. However, upon grouping the breast cancer patients by their estrogen-receptor status, 
no consistent trend was observed between patients with no relapse during the 5-year follow-up 
period and patients with metastatic relapse within 5 years post-treatment for both gene sets, fig. 
S2. These results indicate that the collective dissemination pathway in breast cancer patients 
with differing receptor statuses warrants further study. 
The CCC provides additional information regarding the underlying complexity of collective 
gene expression 
We investigated if the insights described above can be obtained from a straightforward analysis 
of gene expression levels. To determine how the CCCs of different gene networks correlate with 
the expression of these genes in different phenotypic groups, we carried out gene set 
enrichment analysis (GSEA) for different sets of genes on epithelial and mesenchymal cell lines 
from the study by Grosse-Wilde et al. [36] and on the tumor samples from IBC patients and non-
IBC breast cancer patients from the study by Iwamoto et al. [40]. Using the GSEA software 
provided by the Broad Institute [52], we tested for enrichment in the expression of collective 
dissemination associated genes, IBC associated genes, and of the canonical drivers of EMT in 
different phenotypic groups, i.e. epithelial versus mesenchymal cell lines in the data from 
Grosse-Wilde et al. [36] and IBC versus non-IBC patients in the data from Iwamoto et al. [40]. 
The results are shown in fig. 9 (A-F). The expression of collective dissemination associated 
genes is significantly enriched in epithelial cell lines as compared to mesenchymal cell lines (p-
value < 0.001) while IBC associated genes and canonical EMT drivers do not show significant 
enrichment when compared across these two phenotypic groups. On the other hand, expression 
of IBC associated genes is significantly enriched in tumor samples from IBC patients (p-value = 
0.035) while the collective dissemination associated genes and canonical EMT drivers do not 
show significant enrichment on comparing IBC samples with non-IBC breast tumor samples. 
Previous studies have suggested a strong association between expression of E-cadherin protein 
in tumor cells and IBC [53, 54]. We compared the levels of CDH1 (E-cadherin) gene expression 
in tumor samples from IBC and non-IBC patients. There was no significant difference in 
expression levels of CDH1 gene between the two groups in any of the 3 breast cancer patients 
datasets, Iwamoto et al. [40], Boersma et al. [41], and Woodward et al. [21], fig. 9 (G-I). 
Together, these results indicate the CCC need not correlate with differential gene expression 
analysis. In fact, the CCC of a set of genes for two samples with a k-fold change in the 
expression of all genes in the set will be the same. On the other hand, a k-fold change in the 
expression levels of all genes in a set as compared to the background will immensely change the 
gene set enrichment score for that set of genes. The CCC can thus provide insights in addition to 
those that may be obtained from a direct analysis of gene expression data by using GSEA. 
Discussion 
Cancer metastasis via migrating clusters of circulating tumor cells has emerged as a critical 
mechanism of seeding secondary tumors in recent studies [7–10]. Although rare in comparison 
with individually disseminated cancer cells, CTC clusters can efficiently seed secondary tumors 
at distant organ sites [9, 10], and their presence in the bloodstream of cancer patients has been 
shown to be associated with poor disease prognosis, i.e. worse overall survival and worse 
disease-free survival [9]. Understanding the molecular mechanisms underlying collective 
dissemination of tumor cells is, therefore, important for predicting metastasis, which remains 
the principal cause of cancer associated mortalities. Determinants of single cell versus collective 
dissemination of tumor cells, however, remain elusive. Here, we have analyzed the topology of 
the network of genes implicated in collective dissemination of tumor cell clusters. We also 
investigated the topology of the network of genes reported to be differentially expressed in 
patients with inflammatory breast cancer (IBC), a highly aggressive type of breast cancer 
characterized by lymphatic emboli composed of clusters of tumor cells. Taken together, our 
analysis suggests that maintenance of the epithelial phenotype in cancer cells disseminating 
from the primary tumor contributes towards metastasis via collective migration of tumor cells 
as CTC clusters. 
Results suggest that expression of genes differentially expressed in tumor cells migrating as 
clusters as compared to individually migrating tumor cells [10] exhibits a more hierarchical 
organization in epithelial cell lines as compared to mesenchymal cell lines in both, immortalized 
breast cell lines [36] and in the NCI-60 panel of cancer cell lines [38, 39]. Retention of some 
epithelial characteristics by cancer cells disseminating from the primary tumor has been 
reported to contribute towards collective invasion by tumor cells as CTC clusters [10, 55, 56]. A 
more hierarchical organization in the expression of these genes may contribute towards a more 
robust epithelial phenotype in these cell lines [25–28]. Higher hierarchical organization in the 
expression of these genes is also observed in tumor samples from IBC patients as compared to 
tumor samples from non-IBC breast cancer patients. This difference may contribute towards the 
strengthened presentation of epithelial characteristics, cell-cell adhesion and inter-cellular 
communication, in tumor cells from IBC patients that fosters the collective migration of these 
cells from the primary breast lesion [55]. Further, hierarchical expression of collective 
dissemination associated genes is of diagnostic relevance in IBC, thereby strengthening the case 
for IBC as a model system for the study of collective dissemination of tumor cells [19] and 
indicating the usefulness of mechanistic studies of tumor cell dissemination in determining the 
principles underlying IBC. 
Next, we investigated the hierarchical organization in the expression of genes previously 
reported to be differentially expressed in tumor samples from IBC patients as compared to non-
IBC patients [35]. The expression of these genes was more hierarchically organized in IBC 
samples as compared to non-IBC samples across multiple independent datasets. Further, 
epithelial cell lines exhibited a more hierarchical expression of these genes as compared to 
mesenchymal cell lines in both immortalized breast cell lines [36] and in the NCI-60 cell line 
panel composed of 9 different tumor types [38, 39]. Thus, both collective dissemination 
associated and IBC-associated genes exhibited a similar trend of higher CCC in immortalized 
breast cell lines or cancer cell lines as well as in tumor samples from breast cancer patients, 
adding to the existing evidence on collective dissemination via tumor emboli as the 
predominant mode of IBC metastasis and consequent aggressiveness. Intriguingly, the 
expression of canonical EMT inducing transcription factors [46] was more hierarchically 
organized in non-IBC breast cancer samples as compared to IBC samples. Taken together, these 
results reinforce the notion that a complete EMT is not involved in IBC metastasis. Rather, it is 
the collective migration of tumor cells that are able to retain some epithelial characteristics that 
contributes towards the metastatic aggressiveness of IBC. 
Both collective dissemination associated and IBC associated gene sets exhibited a higher CCC in 
breast cancer patients with faster post-treatment metastatic relapse as compared to patients 
with slower post-treatment relapse [47]. A similar trend was observed in our calculations of the 
CCC for patients with SCLC [49], another metastatically aggressive cancer reported to 
metastasize via clusters of tumor cells [48]. These results indicate that a more hierarchical 
organization in the expression of genes involved in the collective dissemination of tumor cells 
may contribute towards a more aggressive behavior in metastatically aggressive tumors such as 
IBC and SCLC, which predominantly metastasize via clusters of circulating tumor cells. A 
mechanism based investigation of the cross-talk between collective dissemination associated 
and IBC associated genes may, therefore, be a promising next step. Further, samples from breast 
cancer metastases to lymph nodes exhibited a lower CCC as compared to breast cancer 
metastases to skin and liver for collective dissemination associated and IBC associated gene sets 
[50]. While metastasis of tumor cells to distant organs is a complex, multi-step, and highly 
inefficient process, migration of tumor cells from the primary tumor to local lymph nodes is a 
more facile process and can be brought about by passive flow of the lymph. Correlation of the 
CCC for both gene sets, collective dissemination associated and IBC associated, with a higher 
rate of and propensity for metastasis to distant organs clearly speaks of the survival advantage 
afforded to migrating tumor cells by collective dissemination as clusters of CTCs. These 
advantages include enhanced ability to resist anoikis (cell death upon detachment from the 
substrate), evasion from immune system recognition, potential polyclonality, and enhanced 
ability to seed secondary tumors [57]. 
A commonly used approach to determine if an a priori defined set of genes is associated with 
phenotypic differences between two groups is gene set enrichment analysis (GSEA) [58, 59]. 
This method involves finding if the given set of genes is over-represented among genes that are 
differentially expressed in the two phenotypic groups. To determine if insights similar to those 
described above can be obtained via GSEA for the collective dissemination associated gene set 
and for the IBC associated gene set, we used the GSEA software provided by the Broad Institute 
[52] to calculate enrichment scores for the two gene sets in the data from Grosse-Wilde et al. [36], 
i.e. epithelial versus mesenchymal cell lines, and in the data from Iwamoto et al. [40], i.e. IBC 
versus non-IBC patients. While we consistently obtained a higher CCC for collective 
dissemination associated and IBC associated gene sets in both epithelial cell lines and tumor 
samples from IBC patients, the expression of these gene sets was not always enriched in 
epithelial versus mesenchymal cell lines or IBC versus non-IBC analysis. These results, thus, 
indicate that the CCC of a gene network can be a robust metric of functional significance of a set 
of genes in different phenotypic groups, independent of the enrichment score calculated for the 
given gene set. The CCC provides a prognostic measure based on the collective expression of 
genes in cells exhibiting different phenotypes beyond that provided by GSEA. 
The classical view of cancer is that it involves de-differentiation of host cell pathways [60]. 
However, structure in the pathways involving genes that promote cancer progression may be 
selected for as the disease advances. We previously showed that the expression of adult acute 
myeloid leukemia associated genes is more hierarchically organized in samples from patients in 
whom the disease relapsed during the follow up period as compared to patients that underwent 
complete remission upon treatment [34]. Similarly, for breast cancer metastasis associated 
genes, hierarchical organization was higher in patients who developed distant metastases as 
compared to patients who did not [33]. Here, we propose that due to the role of maintenance of 
the epithelial phenotype in collective dissemination of tumor cells and the subsequent 
metastatic efficiency of CTC clusters, a hierarchical organization in the expression of these genes 
may be selected for in metastatically aggressive cancers like IBC. A measure of hierarchical 
organization, here the CCC, can thus be a useful biomarker in cancer prognosis, particularly in 
the case of IBC. 
Conclusions 
We have shown that a set of genes previously reported to be associated with the collective 
dissemination of tumor cell clusters [10] is more hierarchically expressed in epithelial cell lines 
as compared to mesenchymal cell lines, thereby indicating a role for epithelial characteristics in 
the collective migration of tumor cells as clusters of circulating tumor cells. We further showed 
that IBC, an aggressive breast cancer subtype that metastasizes primarily via CTC clusters, 
exhibits a more hierarchical organization in the expression of these collective dissemination 
associated genes as compared to non-IBC type breast cancer. Along similar lines, we showed 
that for genes differentially expressed in IBC as compared to non-IBC type breast cancer, the 
expression is more hierarchical in tumor samples from IBC patients and in phenotypically 
epithelial cell lines, suggesting a role for the epithelial phenotype in the metastatically 
aggressive nature of IBC. Taken together, our work indicates that maintenance of the epithelial 
phenotype in disseminating tumor cells during disease progression plays a key role in 
successful metastasis of cancer to distant organs, and that IBC can be a suitable model system 
for studying mechanisms of collective migration of tumor cells and CTC clusters. Further, we 
have introduced the CCC as a quantitative metric for analyzing the collective migration of 
circulating tumor cell clusters, which can be useful in cancer prognosis, particularly in the case 
of IBC. 
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Figures 
 
Figure 1 Normalized CCC for the collective dissemination associated gene network for cell lines 
from two different datasets: (A) epithelial (E) (n = 13) and mesenchymal (M) (n = 11) cell lines 
from the study by Grosse-Wilde et al. [36] and (B) epithelial (E) (n = 11) and epithelial / 
mesenchymal hybrid (E/M) + mesenchymal (M) (n = 47) cell lines from the NCI-60 dataset [38, 
39]. In both datasets, the epithelial cell lines exhibit a higher CCC for collective dissemination 
associated gene network (p-value < 0.05). Error bars indicate the standard error in the estimate 
of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. 
 
 
 
 
 
 Figure 2 Normalized CCC of the collective dissemination associated gene network for tumor 
samples from IBC patients and non-IBC breast cancer patients for data from studies by (A) 
Iwamoto et al. [40] (n = 25 for the IBC group, n = 57 for the non-IBC group), (B) Boersma et al. 
[41] (n = 13 for the IBC group, n = 35 for the non-IBC group), and (C) Woodward et al. [21] (n = 
20 for the IBC group, n = 20 for the non-IBC group). Error bars indicate the standard error in the 
estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. 
 
 
 
 
 
 
 
 
 Figure 3 Normalized CCC for the IBC associated gene network for cell lines from two different 
datasets: (A) epithelial (E) (n = 13) and mesenchymal (M) (n = 11) cell lines from the study by 
Grosse-Wilde et al. [36] and (B) epithelial (E) (n = 11) and epithelial / mesenchymal hybrid (E/M) 
+ mesenchymal (M) (n = 47) cell lines from the NCI-60 dataset [38, 39]. In both datasets, the 
epithelial cell lines exhibit a higher CCC for the IBC associated gene network (p-value < 0.05). 
Error bars indicate the standard error in the estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap 
method. 
 
 
 
 
 
 
 
 Figure 4 Normalized CCC of the IBC associated gene network for tumor samples from IBC 
patients and non-IBC breast cancer patients for date from studies by (A) Iwamoto et al. [40] (n = 
25 for the IBC group, n = 57 for the non-IBC group), (B) Boersma et al. [41] (n = 13 for the IBC 
group, n = 35 for the non-IBC group), and (C) Woodward et al. [21] (n = 20 for the IBC group, n = 
20 for the non-IBC group). Error bars indicate the standard error in the estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 
calculated using the bootstrap method. Tumor samples from IBC patients exhibit a higher CCC 
for the IBC associated gene network as compared to tumor samples from non-IBC breast cancer 
patients (p-value < 0.05 for (A) and (B)). 
 
 
 
 
 
 
 Figure 5 Normalized CCC for the expression of canonical EMT driving transcription factors in 
IBC and non-IBC breast cancer patient groups from studies by (A) Iwamoto et al. [40] (n = 25 for 
the IBC group, n = 57 for the non-IBC group), (B) Boersma et al. [41] (n = 13 for the IBC group, n 
= 35 for the non-IBC group), and (C) Woodward et al. [21] (n = 20 for the IBC group, n = 20 for 
the non-IBC group). Error bars indicate the standard error in the estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated 
using the bootstrap method. 
 
 
 
Figure 6 (A) Normalized CCC of the collective dissemination associated gene network for breast 
cancer patients with metastatic relapse within a 30-month period post-treatment (T < 30; n = 56) 
and with metastatic relapse between 30 and 60 months post-treatment (T ≥ 30; n = 51). Data 
from the study by Wang et al. [47]. (B) Normalized CCC of the IBC associated gene network for 
same groups of breast cancer patients as in (A). (C) Normalized CCC of the collective 
dissemination associated gene network for small cell lung cancer (SCLC) patients with less than 
10 months of disease free survival post-treatment (T < 10; n = 11) and patients with longer than 
10 months of disease free survival post-treatment but death during the follow up period (T ≥ 10; 
n = 10). Data from the study by Rousseaux et al. [49]. (D) Normalized CCC of the IBC associated 
network for the same SCLC patient groups as in (C). Higher CCCs of the collective 
dissemination associated and IBC associated gene networks correlate with a higher rate of 
metastasis, both in breast cancer and small cell lung cancer. Error bars indicate the standard 
error in the estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. 
 
 
 
 
 
 
 
 Figure 7 CCC for tumor samples from breast cancer metastases to different organs [50]: (A) 
Normalized CCC of the collective dissemination associated gene network for breast cancer 
metastases to different sites: skin (n = 17), lymph nodes (n = 39), and liver (n = 16). (B) 
Normalized CCC of the IBC associated gene network for breast cancer metastases to different 
sites as in (A). Error bars indicate the standard error in the estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using 
the bootstrap method. 
 
 
 
 
 
 
 
 
 
Figure 8 For tumor samples from breast cancer patients who exhibit metastatic relapse during 
the follow up period (n = 179) and those who do not exhibit breast cancer relapse (n = 107), from 
the study by Wang et al. [47], normalized CCC for (A) collective dissemination associated gene 
network and (B) IBC associated gene network. Similarly, for breast cancer patient data from The 
Cancer Genome Atlas (TCGA) [51] (n = 13 for the metastasis group, n = 527 for the non-
metastatic group), normalized CCC for (C) collective dissemination associated gene network 
and (D) IBC associated gene network. Error bars indicate the standard error in the estimate of 
𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 9 Top two rows (A-F): enrichment profiles for different gene sets in data from Grosse-
Wilde et al. [36] (top row) and in data from Iwamoto et al. [40] (middle row). Black bars along 
the top of each plot indicate the positions of hits to the gene set along the ordered list of genes 
ranked by correlation to the phenotype. In the top row of plots, there is high correlation with 
the epithelial phenotype on the left and it decreases towards right, epithelial versus 
mesenchymal cell lines GSEA. In the middle row of plots, there is high correlation with the IBC 
phenotype on the left and correlation decreases towards right, IBC versus non-IBC breast tumor 
samples GSEA. Nominal p-values of enrichment are indicated at the bottom of each plot. 
Bottom row (G-I): Mean expression of E-cadherin (CDH1 gene) in tumor samples from IBC and 
non-IBC patients in studies by (G) Iwamoto et al. [40], (H) Boersma et al. [41], and (I) Woodward 
et al. [21]. There is no significant difference in the expression of CDH1 gene in any of the three 
breast cancer datasets. This result indicates that the information provided by the CCC about 
differences in gene expression between tumor samples from IBC and non-IBC patients cannot 
be obtained by studying the differential expression of CDH1, a gene which has previously been 
shown to be associated with IBC [53, 54]. 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary figures 
 
Figure S1 Normalized CCC for estrogen-receptor-positive (ER+) non-IBC breast cancer patients 
with metastatic relapse within a 30-month period post-treatment (T < 30; n = 39) and with 
metastatic relapse between 30 and 60 months post-treatment (T ≥ 30; n = 41). Data from the 
study by Wang et al. [47]. (A) Normalized CCC of the collective dissemination associated genes. 
(B) Normalized CCC of the IBC associated genes. Error bars indicate the standard error in the 
estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. There were too few estrogen-
receptor-negative (ER-) patients in the data set for similar analysis. The trend here is similar to 
the trend in fig. 7 (A). 
 
 
 
 
 
Figure S2 Normalized CCC for breast cancer patients with different estrogen-receptor status, 
data from Wang et al. [47]. Top panel: patients with estrogen-receptor-positive status. This 
group has 129 patients with no relapse during the 5-year follow-up period and 80 patients with 
metastatic relapse within 5 years post-treatment. (A) Normalized CCC for the collective 
dissemination associated genes. (B) Normalized CCC for the IBC associated genes. Bottom 
panel: patients with estrogen-receptor-negative status. This group has 50 patients with no 
relapse during the 5-year follow-up period and 27 patients with metastatic relapse within 5 
years post-treatment. (A) Normalized CCC for the collective dissemination associated genes. (B) 
Normalized CCC for the IBC associated genes. Error bars indicate the standard error in the 
estimate of 𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. 
 
 
 
 
 
 
 
 
  
Figure S3 Top panel: Normalized CCC for epithelial (E) (n = 13) and mesenchymal (M) (n = 11) 
cell lines from the study by Grosse-Wilde et al. [36]. (A) Normalized CCC for genes up-
regulated in cells in circulating tumor cell clusters [10]. (B) Normalized CCC for genes down-
regulated in cells in circulating tumor cell clusters [10]. Bottom panel: Normalized CCC for 
tumor samples from IBC patients (n = 25) and from non-IBC breast cancer patients (n = 57) from 
the study by Iwamoto et al. [40]. (A) Normalized CCC for genes up-regulated in cells in 
circulating tumor cell clusters [10]. (B) Normalized CCC for genes down-regulated in cells in 
circulating tumor cell clusters [10]. Error bars indicate the standard error in the estimate of 
𝐶𝐶𝐶𝑛𝑜𝑟𝑚 calculated using the bootstrap method. In epithelial cell lines, the CCC is higher for 
genes that are up-regulated and for genes that are down-regulated in cells in circulating tumor 
cell clusters, further indicating that the CCC contributes information independent of the levels 
of gene expression. In tumor samples from breast cancer patients, there is no significant 
difference in CCC for up-regulated genes between IBC and non-IBC patient groups, while the 
trend in CCC values for down-regulated genes in opposite to the trend in fig. 2 (A). Taken 
together, these results indicate that collective consideration of both up-regulated and down-
regulated genes is important for understanding the principles underlying phenotypic 
differences between groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure S4 Top panel: Normalized CCC for epithelial (E) (n = 13) and mesenchymal (M) (n = 11) 
cell lines from the study by Grosse-Wilde et al. [36]. (A) Normalized CCC for top 50 genes 
specifically expressed in epithelial cells [36]. (B) Normalized CCC for top 50 genes specifically 
expressed in mesenchymal cells [36]. Bottom panel: Normalized CCC for tumor samples from 
IBC patients (n = 25) and from non-IBC breast cancer patients (n = 57) from the study by 
Iwamoto et al. [40]. (A) Normalized CCC for top 50 genes specifically expressed in epithelial 
cells [36]. (B) Normalized CCC for top 50 genes specifically expressed in mesenchymal cells [36]. 
CCCs for both gene sets do not differ significantly between epithelial and mesenchymal cell 
lines, once again indicating the independence of CCC from gene expression levels and related 
metrics. Comparing CCCs for both gene sets between IBC and non-IBC patient groups, there is 
no significant difference, indicating that the IBC phenotype may not directly correlate with 
epithelial cell associated genes or with mesenchymal cell associated genes. 
